Professor Syed Haq is a Professor of Medicine and specialises in treating the ageing brain/skin and immune system. He is the Founder of BioImmunitas Ltd, which is focused on developing pharmaceutical therapeutics for targeting systemic inflammatory disorders and COVID-19 by recalibration of the innate immune system, as well as a co-Founder of the AM Aesthetics clinics in London, Belfast and Derry.

Professor Haq has overseen several MHRA-registered clinical trials in the UK and has been awarded two US FDA Orphan Drug Designations. Since 2007, he has advised and acted as International KOL for Merz, Teoxane, Q-med,Bioform, Ipsen, Galderma, Croma and is a consultant for Hugel.